meglumine has been researched along with Arthritis, Psoriatic in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnadas, MA; Català, A; Muñoz, C; Puig, L | 1 |
| Aguado-Lobo, M; Borbujo, J; Espinosa-Lara, P; García-Donoso, C; Martínez-Sánchez, D; Moreno-Torres, A; Romero-Maté, A; Tardío, JC | 1 |
2 other study(ies) available for meglumine and Arthritis, Psoriatic
| Article | Year |
|---|---|
Cutaneous leishmaniasis in a patient receiving infliximab for psoriatic arthritis: treatment with cryotherapy and intralesional meglumine antimonate.
Topics: Adult; Antiprotozoal Agents; Antirheumatic Agents; Arthritis, Psoriatic; Combined Modality Therapy; Cryotherapy; Humans; Infliximab; Injections, Intralesional; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds | 2014 |
Cutaneous leishmaniasis with histopathologic pattern of non-necrotizing granulomatous dermatitis in patients treated with adalimumab.
Topics: Adalimumab; Antibodies, Antinuclear; Antibodies, Monoclonal, Humanized; Arthritis, Psoriatic; Arthritis, Rheumatoid; Drug Therapy, Combination; Female; Granuloma; Humans; Leishmaniasis, Cutaneous; Meglumine; Meglumine Antimoniate; Methotrexate; Middle Aged; Organometallic Compounds | 2012 |